Hedbäck G, Abrahamsson K, Odén A
Sahlgrenska University Hospital, Göteborg University, S-413 Göteborg, Sweden.
Eur J Clin Invest. 2001 Dec;31(12):1048-53. doi: 10.1046/j.1365-2362.2001.00926.x.
Improvement of renal concentration capacity was long ago shown to occur after surgery for primary hyperparathyroidism (pHPT). Study of concentration capacity is of interest, as it was also shown to be a predictive factor for the risk of death in patients with pHPT, and it affected the risk of death independently of 33 other variables in multivariate analysis.
There were 98 patients with verified pHPT operated on in the years 1958-81, who had urine osmolality determinations performed both before and after surgery: 63 immediately after, and 35 with mean 3.9 years delay (SD = 1.8). Another seven patients with pHPT had urine osmolality determinations performed preoperatively only. Non-parametric sign tests, regression analysis, and correlation tests were performed.
Both patients with severe or moderate, and mild pHPT showed a substantial change of renal concentration capacity, with mean increase of 28.3% (SD = 28.4). The increase generally occurred soon after surgery. In eight out of 98 patients, there was no improvement. A relationship was found between improvement and preoperative peak serum calcium level. In seven out of seven patients followed, untreated for mean 5.3 years (SD = 3.2), there was a mean 15% (SD = 8.0) deterioration of renal concentration capacity.
The findings of this study add cause for surgery in patients with pHPT and give no reason for different treatment of severe, moderate or mild disease.
很久以前就已表明,原发性甲状旁腺功能亢进症(pHPT)手术后肾脏浓缩功能会得到改善。对浓缩功能的研究具有重要意义,因为它也是pHPT患者死亡风险的一个预测因素,并且在多变量分析中,它独立于其他33个变量影响死亡风险。
1958年至1981年期间,对98例经证实的pHPT患者进行了手术,这些患者在手术前后均进行了尿渗透压测定:63例术后立即测定,35例平均延迟3.9年(标准差=1.8)测定。另外7例pHPT患者仅在术前进行了尿渗透压测定。进行了非参数符号检验、回归分析和相关性检验。
重度或中度以及轻度pHPT患者的肾脏浓缩功能均有显著变化,平均增加28.3%(标准差=28.4)。这种增加通常在手术后不久就会出现。98例患者中有8例没有改善。发现改善与术前血清钙峰值水平之间存在关联。在随访的7例患者中,平均5.3年(标准差=3.2)未接受治疗,肾脏浓缩功能平均恶化15%(标准差=8.0)。
本研究结果为pHPT患者进行手术增添了理由,且没有理由对重度、中度或轻度疾病进行不同的治疗。